AFC-HD AMS Life Science Co.,Ltd.JP:2927Income statement

Market cap
¥12.7B
P/E ratio
8.5x
2011/082012/082013/082014/082015/082016/082017/082018/082019/082020/082021/082022/082023/082024/082025/08
Revenue14,65414,79514,36613,72814,41514,63115,14215,79616,25315,81922,36822,99725,57930,18532,655
Revenue growth (%)-
Cost of revenue---9,61610,15410,24110,53411,20311,73211,26515,50314,41816,25619,69421,394
Gross profit---4,1124,2614,3904,6084,5934,5214,5556,8658,5799,32310,49211,261
Gross margin (%)---
Operating margin (%)---
Operating expenses ---3,5483,3103,4993,5393,5693,5403,4614,6207,5687,6878,5738,852
Operating income ---5659518911,0691,0239811,0932,2451,0111,6361,9192,409
Income before tax 9966748185088928121,0409821,0151,0992,1611,3431,6541,9242,443
Pretax margin (%)6.84.65.73.76.25.66.96.26.26.99.75.86.56.47.5
Provision for income taxes---211356269171249308328662498459676732
Effective tax rate (%)---
Net income 4905695722836064904667377836771,4967381,0871,244706
Net income margin (%)
Earnings per share41.1347.7448.1423.8250.6440.4738.4858.2855.748.12107.1252.3377.1488.64102.98
Diluted EPS41.1247.7448.1423.485040.3438.4858.2855.748.12106.352.0878.4689.11102.97
Dividend payout ratio (%)--------
Dividend per share--------252027.53027.53034
EBITDA---
EBITDA margin (%)---